Abstract: FR-PO006
TNFR-1, TNFR-2, and KIM-1 Plasma Concentrations After COVID-19 and Association With Kidney Function
Session Information
- COVID-19: AKI Outcomes, Biomarkers, Treatments, Case Reports
November 04, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
Abstract Time: 10:00 AM - 12:00 PM
Category: Coronavirus (COVID-19)
- 000 Coronavirus (COVID-19)
Authors
- Chan, Lili, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Anandakrishnan, Nanditha, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Saha, Aparna, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Defronzo, Stefanie, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Mosoyan, Gohar, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Meliambro, Kristin, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Wisnivesky, Juan, Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Nadkarni, Girish N., Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Stapleton, Sharon, Renalytix, New York, New York, United States
- Fleming, Fergus, Renalytix, New York, New York, United States
- Coca, Steven G., Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Azeloglu, Evren U., Icahn School of Medicine at Mount Sinai, New York, New York, United States
Background
Biomarkers TNFR1, TNFR2, and KIM1 are associated with progression of kidney disease. These biomarkers have not been evaluated in patients who have recovered from COVID-19.
Methods
Patients who had COVID-19 and recovered were followed longitudinally at an outpatient clinic with labs and surveys as part of the Mount Sinai Post-COVID clinic. Blood was sent for creatinine at baseline and 6 month follow up visit. We measured plasma TNFR1, TNFR2, and KIM-1 from the first post-COVID visit via Renalytix’ proprietary multiplex assay. eGFR was calculated using the 2021 CKD-EPI formula.
Results
450 COVID survivors had serum creatinine values measured at baseline (222±89 days post-COVID) and 6 month (419±97 days post-COVID) follow up. The average age of patients was 50±14 years, 62% were female, 60% were white, and 17% were Black. 23% were hospitalized, 4% required ICU admission, and 2% of patients reported AKI. eGFR at the baseline visit was 94±21 and at 6-months was 96±22 ml/min/1.73m2. At the baseline visit, KIM-1, TNFR-1, and TNFR-2 levels were highest in patients who were hospitalized and had AKI (Figure 1a) and concentrations of all three were associated with lower eGFR 6 months later (Figure 1b).
Conclusion
Severity of illness during COVID is associated with higher levels of plasma TNFR1, TNFR2, and KIM1 several months after recovery. The degree of biomarker elevation post-COVID was associated with lower kidney function more than 1 year post-COVID.
Funding
- Commercial Support –